Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics
Clinical trial NCT02821416 · COMPLETED
Trial details
- NCT number
- NCT02821416
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-11
- Primary completion
- 2019-10-22
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.